• Other Philanthropy, Voluntarism, and Grantmaking Foundations N.E.C.

• 928.

U B Foundation Services Inc

THE ORGANIZATION'S MISSION IS TO CARRY OUT THE PURPOSES OF THE UNIV.

American Federation for Aging Research (AFAR), Inc.

The American Federation for Aging Research's mission is to support and advance healthy aging through biomedical research, including development of the next generation of aging researchers.

J G B Rehabilitation Corp

Husband, Father, Brother, Friend, Beatboxer, and a Classic Americana Barber Lighthouse Guild's official Facebook page.

• Neurology, Neuroscience

• 931.

Society of Vascular and Interventional Neurology

Society of Vascular and Interventional Neurology; Journal @SVINJournal; Research @SVINRegistry; Global Outreach @MTrombectomy SVIN is a society enabling great neurologists and interventionists to come together in order to help patients and advance our field.

• Epilepsy

• 932.

CHELSEA HUTCHISON FOUNDATION

The Chelsea Hutchison Foundation raises funds to provide grants for trained seizure-response dogs and movement monitors for those in need.

MY EPILEPSY STORY INC

My Epilepsy Story (MES) ,a nonprofit that is “Bridging the Gap” for women & girls with epilepsy.

Pacs1 Syndrome Research Foundation

THE GOAL OF THE PACS1 SYNDROME RESEARCH FOUNDATION IS TO FIND A TREATMENT FOR PACS1 SYNDROME (A DEBILITATING NEURO-GENETIC DISEASE) IN THE SHORTEST POSSIBLE TIME-FRAME BY FUNDING CUTTING-EDGE SCIENTIFIC RESEARCH About Us Contact Registry Scientific Advisory Board Funded Research More Funding Scientific Research to find Treatments for PACS1 Syndrome JOIN US DONATE AND MAKE A DIFFERENCE TODAY.

• Brain Disorders

• 935.

Georgetown Neurosciences Foundation

THE GEORGETOWN NEUROSCIENCE FOUNDATION IS A GRASSROOTS 501(C)3 NONPROFIT DEDICATED TO GIVING PEOPLE CONTROL OF THEIR BRAIN HEALTH THROUGH RESEARCH, EDUCATION AND OUTREACH.

• Fund Raising and/or Fund Distribution

• 936.

TO CURE A ROSE FOUNDATION

At To Cure A Rose Foundation, we’re on a mission to make genetic treatments faster, more affordable, and within reach—so that the next child born with a rare disease can receive a customized drug within days of diagnosis.